Hasuoka Atsushi, Nishikimi Yuji, Nakayama Yutaka, Kamiyama Keiji, Nakao Masafumi, Miyagawa Ken-ichiro, Nishimura Osamu, Fujino Masahiko
Pharmaceutical Research Division, Takeda Chemical Industries, Ltd, Osaka, Japan.
J Antibiot (Tokyo). 2002 Mar;55(3):322-36. doi: 10.7164/antibiotics.55.322.
The novel natural antibiotics pyloricidin A, B and C possess potent and highly selective antibacterial activity against Helicobacter pylori. In order to investigate the structure activity relationships for the terminal peptidic moiety, a series of pyloricidin B and pyloricidin C derivatives, bearing various amino acids in the moiety, were prepared and evaluated for their anti-H. pylori activity. The derivatives bearing alpha-D-, beta- and gamma-amino acids or peptidemimetics showed drastically decreased activity. On the other hand, the derivatives with a-L-amino acids were found to maintain the activity. Among the derivatives prepared in this work, the allylglycine derivative 2s showed the most potent anti-H. pylori activity, with an MIC value of less than 0.006 microg/ml against H. pylori NCTC11637, which is 60-fold greater than the activity of the lead compound pyloricidin C.
新型天然抗生素幽门菌素A、B和C对幽门螺杆菌具有强大且高度选择性的抗菌活性。为了研究末端肽部分的构效关系,制备了一系列在该部分带有各种氨基酸的幽门菌素B和幽门菌素C衍生物,并评估了它们的抗幽门螺杆菌活性。带有α-D-、β-和γ-氨基酸或肽模拟物的衍生物活性急剧下降。另一方面,发现带有α-L-氨基酸的衍生物保持了活性。在这项工作中制备的衍生物中,烯丙基甘氨酸衍生物2s表现出最强大的抗幽门螺杆菌活性,对幽门螺杆菌NCTC11637的最低抑菌浓度(MIC)值小于0.006微克/毫升,比先导化合物幽门菌素C的活性高60倍。